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Abstract: Amphibian skin secretion has great potential for drug discovery and contributes 
hundreds of bioactive peptides including bradykinin-related peptides (BRPs). More than  
50 BRPs have been reported in the last two decades arising from the skin secretion  
of amphibian species. They belong to the families Ascaphidae (1 species), Bombinatoridae  
(3 species), Hylidae (9 speices) and Ranidae (25 species). This paper presents the diversity 
of structural characteristics of BRPs with N-terminal, C-terminal extension and amino acid 
substitution. The further comparison of cDNA-encoded prepropeptides between the different 
species and families demonstrated that there are various forms of kininogen precursors  
to release BRPs and they constitute important evidence in amphibian evolution.  
The pharmacological activities of isolated BRPs exhibited unclear structure–function 
relationships, and therefore the scope for drug discovery and development is limited. 
However, their diversity shows new insights into biotechnological applications and, as a 
result, comprehensive and systematic studies of the physiological and pharmacological 
activities of BRPs from amphibian skin secretion are needed in the future. 
Keywords: amphibian; bradykinin-related peptide; biosynthetic kininogen; bradykinin agonist 
and antagonist 
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1. Introduction 
The skin secretions of amphibians have been widely studied over the past several decades. A plethora 
of biologically active compounds have been isolated and identified from their granular glands including 
alkaloids, steroids, bioorganic amines, peptides and proteins [1–3]. Bioactive peptides are predominant 
and remarkable in amphibian skin secretion as a large amount of antimicrobial peptides, physiological 
active peptides and neurotransmitter like peptides have been discovered [4–6]. These peptides are 
considered to be an important part of their innate immune system, enabling them to have survived 
predators and infection from microorganisms for millions of years [2]. 
Historically, bradykinin (BK) and BRPs from amphibian skin were first reported by Erspamer’s group 
in the 1960s through the 1970s [7,8]. BK is the final product of the kallikrein–kinin system in the 
mammalian blood system, and is liberated from three types of kininogens: high molecular weight 
kininogens and low molecular weight kininogens encoded by a single gene, which are found in humans, 
and T-kininogens found in rats. All three types consist of a heavy chain and light chain, connecting 
through a disulphide bridge [9–11]. 
Unlike the releasing processes of BK and its large sized precursors in mammalians, amphibian BK 
demonstrates extreme differences. There is no kallikrein–kinin system in amphibians [12,13]. BK and 
BRPs are produced from amphibian skin glands as immune defence peptides, in contrast to playing 
important roles in endogenous hormonal activity in other higher vertebrate groups [12–15]. BRPs from 
amphibians are widely studied not only for their diversity of BK homologues which are displayed as  
N-terminal, C-terminal extension, insertion and amino acid substitution, but also for their potential in  
relation to drug development especially in the fields of blood pressure regulation and inflammatory reactions. 
Since 1962, Erspamer and his colleagues reported that BRPs exist in amphibian skin extracts [16].  
A large array of BRPs have been isolated and identified from many families, including Ascaphidae  
(1 species), Bombinatoridae (3 species), Hylidae (9 speices) and Ranidae (25 species). More than a 
hundred results are shown if the search term “amphibian and bradykinin” is used through Uniprot Data 
base (Pubmed access time: 7 December 2014). Whilst this is not a large amount compared to other kinds 
of skin defence peptides, such as antimicrobial peptides, of which there are nearly 2000 records in the 
Data base (Pubmed access time: 7 December 2014), BRPs have the largest number of analogues. When 
compared to BK, a high and varying degree of structural changes occur through four main characteristics: 
N-terminal extension, C-terminal extension, segment insertion and amino acid substitutions and the 
cloned cDNAs illustrated by the phenomenon of single copy or multiple tandem copies of mature peptide 
in a full-length cDNA sequence. 
2. The Distribution of BRPs among Amphibian 
2.1. BRPs from Ascaphidae 
Ascaphidae is an ancient amphibian family with only one genus, Ascaphus. Representatives of this 
genus are found in North America in a small area off the west coast of Canada and the United States 
(The IUCN red list access time: 10 January 2015). Conlon and his colleagues reported BK and three 
BRPs in the species of Ascaphus truei [17]. As shown in Table 1, mammalian BK and an analogue with 
two Val-Asp amino acid extensions at C-terminals were isolated. In addition, the skin glands secreted 
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Ala0, Pro1, Val2, Leu5-BK and its analogue extended by Val-Val at C-terminals. These peptides were 
isolated through reverse-phase chromatography and identified by Edman degradation alone without 
identification of their cDNA-encoded precursors. A five amino acid residues sequence (FSPFR) is 
identical to BK, which accounts for the three BRPs induced myotropic activities on isolated mouse 
trachea [17]. It has been postulated that these peptides are liberated from multiple duplications of an 
ancestral gene. However, due to the lack of records of their encoded gene information, their prepropeptide 
precursors cannot be determined. This suggests that the processing of the release and proteinase cleavage 
arising from their precursors requires further study. 
Table 1. Bradykinin-related peptides (BRPs) isolated from skin secretion of Ascaphidae. 
Peptides were aligned to compare to conventional bradykinin. AR-10, AV-12 and RD-11 
were named in accordance of first and last amino acid and the number of amino acid residues. 
Name Peptide Sequence Species 
BK RPPGFSPFR Ascaphus truei [17] 
AR-10 APVPLFSPFR Ascaphus truei [17] 
AV-12 APVPLFSPFRVV Ascaphus truei [17] 
RD-11 RPPGFSPFRVD Ascaphus truei [17] 
2.2. BRPs from Bombinatoridae 
Only three species have been studied in isolation of BRPs in this family: Bombina maxima, Bombina 
orientalis and Bombina variegata (Table 2). The most notable peptide group is bombinakinin, including 
bombinakinin M, an N-terminal 10 amino acid residues extended BRP from the skin secretion of 
Bombina maxima [18,19] and bombinakinin O, an C-terminal extended BRP, from the skin secretion of 
Bombina orientalis [20]. It was first reported that the cDNA-encoded precursor contained six identical 
copies of bombinakinin M [18]. However, in subsequent studies, the structures of bombinakinin M 
prepropeptide precursors have been reported in multiple forms. The prepropeptide precursor containing 
three identical bombinakinin M copies was reported by Chen et al. [19]. One precursor was reported by 
Lai [21]; it contained eight copies of bombinakinin M and following a bombinakinin-GAP, a 28 amino 
acid peptide of limited similarity to BK. Another two precursor variants were identified by Lee,  
one which contains two bombinakinin M replicates and the other contains a single copy (Figure 1a) [22].  
It is unclear whether the peptide arising from different cDNA-encoded precursors comes from one single 
species since different methodologies were used inadvertently [19]. The results from the release of 
identical mature peptides, shown as the difference of the number of copies in precursors, suggest the 
possibility of the anomalies occurring in skin secretion due to the variation of gene expression regulation 
arising for some unknown reason. 
Mammalian BK and four analogue peptides with amino acids substitutions have been identified. 
BRPs from Bombina orientalis and Bombina variegate were demonstrated to be threonine amino acid 
residue substitution at position 6, which commonly occurs in other amphibian families such as Hylidae 
and Ranidae described below. They demonstrated highly conserved sequences of mature peptides but 
the cDNA-encoded prepropeptide precursors displayed differential features. 
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(a) 
(b) 
Figure 1. (a) cDNA-encoded biosynthetic precursors are identified from skin secretion of 
Bombina maxima; (b) cDNA-encoded biosynthetic precursors are identified from skin secretion 
of Bombina orientalis and Bombina variegate. BOK and BVK represent preprobradykinin 
kininogens from Bombina orientalis and Bombina variegate, respectively. The putative signal 
peptide sequences are shown in italic typeface and the mature peptide sequences are 
represented in bold typeface. The access numbers are shown after the name of each precursor. 
  
Kininogen-1b (Q90WZ1) 
MRLWFCLSFFIVLC 
LEHFPETLADERNVPESEEKTEQYLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR  
DLPKINRKGPRPPGFSPFRGKFHSQSHV   
Kininogen-1c (Q90W88) 
MRLWFCLSLFIVLC 
LEHFPGTLADERNVPESEEKTEQFLR 
DLPKINRKGPRPPGFSPFRGKFHSQTLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DLPKINRKGPRPPGFSPFRGKFHSQSHV!
Kininogen-1a (Q7T3L1) 
MRLWFCLSFFIVLC 
LEHFTGTLADERNVPESEEKTEQFLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR  
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DMYEIKQYKTAHGRPPICAPGEQCPIWVGK 
Bombinakinin M variant (Q5GC95) 
MRLWFCLSFFIVLC 
LEHFPGTLADERNNR 
DYSIKTSIHGHHIERNNR 
DYTIRTRLHGHHKPRNNR 
DYTIRTRLHGHHKPRNVPESEEKTEQFLR 
DLPKINRKGPRPPGFSPFRGKFHSQSLR 
DLPKINRKGPRPPGFSPFRGKYQRQSLR 
QIPGLGPLRG 
Bombinakinin M variant (Q5GC96) 
MRLWFCLSFFIVLC 
LEHFTGTLADERNNR 
DYSIKTSIHGHHIERNNR 
DYTIRTRLHGHHKPRNNR 
DYTIRTRLHGHHKPRNVPESEEKTEQFLR 
DLSKMSFLHGIPPGFSPFRGKYQRQSLR 
QIPGLGPLRG 
BOK-1 (P83060) 
MRLWFCLSFFIILC 
LEHFPGTLADERNVPESEEKTEQFLRDLSEISRLQR 
RPPGFSPFRGKFHSQSLRDLSEISRLQR 
RPPGFSPFRGKFHSQSMRDLSEISRLQR 
RPPGFSPFRGKFHSQSMRDLSEISRLQR 
RPPGFSPFRGKFHSQSLRGLSEIKRLKTTHKIH 
BOK-2 (P83059)
MRLWFCLSFFVVLC 
LEHFPGTLADERNNRDYPIRTHLHGPHIPRNNR 
DYPIRTHLHGHHIPRNVPESEEKTEQFLRDLSEISRLQR
RPPGFTPFRGKFHSQSLRDLSEISRLQR  
RPPGFTPFRGKFHSQSLR 
DMYEIKGFKSAHGRPRVCPPGEQCPIWVG!
BVK-1 P83056 
MRLWFCLSFLIILC 
VEHFPGTLAVERNVPESEEKTEQFLRDLFEISRLQR 
RPAGFTPFRGKFHSQSLRGLSET 
KRIYNAIWPCKHCNKCKPGLLCKK!
BVK-2 P83057
MILWFCLNFLIVLC 
LEHFPGTLAAERNVPQSEEKTEQFLRDLSEISRLQR 
VPTGFTPFRGKFHSQSLRGLSET 
KKFKAPYNIHWHCKPGLLCKNFN 
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Table 2. BRPs isolated from skin secretion of Bombinatoridae. Peptides are aligned in order 
to compare to the conventional BK. 
Name Peptide Sequence Species 
BK RPPGFSPFR Bombina orientalis [23] 
Bombinakinin M DLPKINRKGPRPPGFSPFR Bombina maxima [18,19,21,22]
Bombinakinin O RPPGFSPFRGKFH Bombina orientalis [20] 
Thr6-BK RPPGFTPFR Bombina orientalis [24] 
Ala3, Thr6-BK RPAGFTPFR Bombina variegata [25] 
Val1, Thr3, Thr6-BK VPTGFTPFR Bombina variegata [25] 
pGlu1, Ile2, Leu5, Gly6, Leu8-BK QIPGLGPLR Bombina maxima [26] 
It has also been reported that the kininogens from Bombina orientalis encoded multiple copies, four 
identical replicates of BK in preprobradykinin-1 (BOK-1) and two identical copies with a variant called 
DV-28 in preprobradykinin-2 (BOK-2) [23,24]. Compared to the preprobradykinin precursors  
(BVK-1 and BVK-2) from Bombina variegate, four preprobradykinin kininogens demonstrated  
highly conserved sequences between their signal peptides (Figure 1b) [25]. It is possible that the  
peptide-encoding gene has evolved into multiple lengths and produced variants of mRNA due to the 
changes of their living condition. 
The pGlu1, Ile2, Leu5, Gly6, Leu8-BK, namely the kinestatin, was isolated from Bombina maxima and 
the cDNA-encoded prepropeptide has two tandem mature peptide sequences, bombinakinin M and 
kinestatin. The primary structure revealed little similarity to conventional BK [26]. It antagonizes  
BK-induced arterial smooth muscle relaxation by targeting the B2 receptor [26]. Similar to  
Leu8-BK which has been reported as a BK receptor antagonist [27], kinestatin also has Leu residue at 
position 8 and hence demonstrates antagonist activity. Meanwhile, the other site substitutions contribute 
to structural changes, which may result in the transformation of agonist into antagonist as well. 
2.3. BRPs from Hylidae 
Hylidae is one of the largest families among amphibians, containing 944 species. The BRPs 
discovered in this family all have been reported from Phyllomedusinae, a sub-family which contains  
59 species [28]. The BRPs isolated from Phyllomediusinae display only one single copy of mature 
peptide sequence in their precursors and show identical topological structures, as opposed to the peptides 
isolated from Bombinatoridae and Ranidae, which display multiple copies of mature peptide sequence 
in the precursors (Figure 2) [29–31]. One possible reason behind the difference in proprepeptide 
sequence is because the species in this sub-family spend almost their entire lives on the tree during the 
spawning and tadpole stage, and this lifestyle helps to maintain secretions over their surface more easily 
than amphibians living in the water or buried in sand, mud and even fallen leaves. This unique lifestyle 
possibly reduces the necessity of expressing different defence peptide precursors to adapt to different 
living conditions. 
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Figure 2. Biosynthetic precursors were identified from skin secretion of the amphibian family, 
Hylidae. The species and their access numbers are shown before the alignments of each 
precursor. The classic prepropeptide convertase processing sites –KR– are shown in bold 
typeface. The putative acidic amino acid residues rich peptides were located between  
two –KR– in each case. The regions with a single underline indicate highly conserved 
sequences as compared to conventional BK. 
BRPs aligned here (Table 3) generally demonstrate the diverse BRPs sequences isolated from 
Phyllomedusinae skin secretion. Amino acid residue substitutions mainly occurred at two sites: valine 
for arginine at position 1 and threonine for serine at position 6. Of interest, some desArg9 peptides were 
isolated from skin secretion of Hylidae and Ranidae. The presence of desArg9 BK and BRPs, the 
peptides showing a high degree of affinity for the B1 receptor, indicates that targeting of the B1 receptor 
might be an important defence strategy against their predators. However, another possibility is that 
because there are some internal enzymes like ACE in the amphibian body, they may cleave the Arg9 
from their conventional peptides. This interaction may contribute to the presence of these desArg9 
peptides in their skin secretion. 
Table 3. BRPs isolated from skin secretion of Hylidae. Peptides are aligned to compare to 
conventional BK. The proline residues with single underline represent the post-translational 
modification of hydroxyproline. The tyrosine residues with double underline represent the 
post-translational modification of O-sulfate. 
Names Peptide Sequences Species 
BK RPPGFSPFR 
Phasmahyla jandaia [32] 
Phyllomedusa azurea [30] 
Phyllomedusa hypochondrialis [33,34] 
desArg9-BK RPPGFSPF Phasmahyla jandaia [32] 
Hyp3-BK RPPGFSPFR Phyllomedusa azurea [30] 
desArg9, Hyp3-BK RPPGFSPF Agalychnis callidryas [35] 
Thr6-BK RPPGFTPFR 
Agalychnis callidryas [31,35] 
Pachymedusa dacnicolor [31] 
Phasmahyla jandaia [32] 
Phyllomedusa azurea [30] 
Phyllomedusa hypochondrialis [31,33,34] 
desArg9, Thr6-BK RPPGFTPF 
Phasmahyla jandaia [32] 
Phyllomedusa azurea [30] 
Phyllomedusa hypochondrialis [31,33,34] 
  
Phyllomedusa azurea (Q0VTT9)   MSFLKKSLFLVLFLGLVSSSICEEE KR ETEEEENEDEIEEESEEK   KR  EDPERPPGFTPFRVY  
Phyllomedusa azurea (Q0VTU0)   MSFLKKSLFLVLFLGLVSFSICEEE KR ETEEEENKDETEEQSEEK KR  FEPVPPGFTPFRLT  
Phyllomedusa azurea (Q0VTT8)   MSFLKKSLFLVLFLGLVSFSICEEE KR ETEEEENEDEIEEQSEEK  KR  FEPVPPGFTPFRQT  
Phyllomedusa sauvagei (Q800F1)   MDILKKSLFLVLFLGLVSFSICEEE KR DTEEEENDDEIEEESEEK  KR  EAPERPPGFTPFRIY  
Phyllomedusa hypochondrialis (P84900)  MSILKKSLFLVLFLGLVSFSICEEE KR EAEEEENEDEIEEESDEK   KR  ESPDRPPGFSPFRIY  
Phyllomedusa hypochondrialis (L0PHN1)  MSILKKSLFLVLFLGLVSFSICEEE KR EAEEEENEDEIEEQSEEK   KR  FEPVPPGFTPFRQS  
Pachymedusa dacnicolor (L0PIN3)   MSFLKKSLFLVLFLGFVSFSICEEE KR EDEEEENEREENKESEE    KR  NQEERPPGFTPFRVD
Agalychnis callidryas (L0PJV8 )   MSFLKKSLFLVLFLGLVSFSICEEE KR ETEEEENEDEMDKESEE   KR  ESPERPPGFTPFRVD 
Phyllomedusa nordestina (K9N1K1)          --HVFLKKSLLLVLSLGWVPFPICEKE KR EAEEEENEDEIEEQSEEK KR  FEPVPPGFTPFRLT  
Phyllomedusa nordestina (K9N2T7)           --MFFLKKFLFLGLFLGLVSFSICEEE KR ETEEEENEDEIEEQSEEK   KR  FEPVPPGFTPF  
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Table 3. Cont. 
Names Peptide Sequences Species 
Hyp3, Thr6-BK RPPGFTPFR Agalychnis callidryas [31] Pachymedusa dacnicolor [31] 
Thr6-BK-Val, Asp RPPGFTPFRVD Pachymedusa dacnicolor [31] Agalychnis callidryas [31] 
Hyp3, Thr6-BK-Val, Asp RPPGFTPFRVD Agalychnis callidryas [31] Pachymedusa dacnicolor [31] 
Val1, Thr6-BK VPPGFTPFR 
Phyllomedusa azurea [29,30] 
Phyllomedusa hypochondrialis [31,34] 
Phyllomedusa sauvagei [29] 
Val1, Hyp2, Thr6-BK VPPGFTPFR Phyllomedusa azurea [30] 
desArg9, Val1, Thr6-BK VPPGFTPF Phyllomedusa hypochondrialis [31,34] 
Val1, Thr6-BK-Leu VPPGFTPFRL Phyllomedusa azurea [30] 
Val1, Thr6-BK-Leu,Thr VPPGFTPFRLT Phyllomedusa azurea [30] 
Glu, Pro-Val1-BK-Leu, Thr EPVPPGFTPFRLT Phyllomedusa azurea [30] Phyllomedusa nordestina [36] 
Val1, Thr6-BK-Gln VPPGFTPFRQ Phyllomedusa hypochondrialis [31,34] 
Val1, Thr6-BK-Gln, Ser VPPGFTPFRQS Phyllomedusa azurea [30] Phyllomedusa hypochondrialis [31,34] 
Val1, Hyp2, Thr6-BK-Gln, Ser VPPGFTPFRQS Phyllomedusa azurea [37,38] Phyllomedusa hypochondrialis [31,34] 
Val1, Hyp2, Thr6-BK-Gln, Thr VPPGFTPFRQT Phyllomedusa azurea [30] 
Val1, Thr6-BK-Gln, Asp VPPGFTPFRVD Phyllomedusa hypochondrialis [31,34] 
PK * RPPGFSPFRIY 
Phasmahyla jandaia [32] 
Phyllomedusa bicolor [39] 
Phyllomedusa hypochondrialis [33,34] 
Phyllomedusa rohdei [40] 
Hyp3-PK * RPPGFSPFRIY Agalychnis callidryas [35] Phyllomedusa hypochondrialis [33,34] 
Thr6-PK * RPPGFTPFRIY 
Pachymedusa dacnicolor [41,42] 
Phasmahyla jandaia [32] 
Phyllomedusa hypochondrialis [33,34] 
Phyllomedusa sauvagei [29] 
Hyp3, Thr6-PK * RPPGFTPFRIY Pachymedusa dacnicolor [41,42] Phyllomedusa sauvagei [29] 
Thr6, Val10-PK * RPPGFTPFRVY Phyllomedusa azurea [30] 
Asp, Pro, Glu-Thr6, Val10-PK * DPERPPGFTPFRVY Phyllomedusa azurea [30] 
* Both O-sulfate and non-sulfate forms of phyllokinin identified from the skin secretion in each case. 
There are only two isolated BRPs displaying the structural variation of N-terminal extensions.  
They are Glu, Pro-Val1-BK-Leu, Thr and Asp, Pro, Glu-Thr6, Val10-phyllokinin (PK). However, in the 
reported data of the cDNA encoded peptide precursors from the skin secretion of Phyllomedusinae frogs, 
all BRPs demonstrated this similar N-terminal extension of tri or tetra amino acid residues in their 
prepropeptide precursors and the extended region all followed one typical propeptide convertase 
processing site, –KR– (Figure 2). In most cases, the extended region contains acidic amino acid residue 
and they were cleaved to generate the mature peptides. It is speculated that the release of mature peptides 
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might be processed by the cleavage at the –KR– site followed by a specific enzymatic interaction.  
It was explained as a particular structural feature for producing post-translational modification of these 
BRPs [29,30], and more research is required. 
The unique kind of peptide in the skin secretion of sub-family Phyllomedusinae is phyllokinin (PK), 
which displays two amino acid residues Ile-Tyr extended at C-terminals. PK was first reported from the 
studies of skin of Phyllomedusa rohdei with a post-translational modification of tyrosine O-sulfation  
and this peptide was subsequently discovered from other species in this sub-family [29,32,33,35,41,42].  
Similar to PK, some of the BRPs were C-terminal extended with one or two amino acid residues, which 
are considered to be more potent than conventional BK because the extended region could inhibit the 
enzymatic metabolism of degradation of the BRPs, which prolong the ligand-receptor interaction [43]. 
However, it was reported that the influences of this kind of C-terminal extension are different in their 
pharmacological effect on multiple tissue preparation [34]. Although these analogues have less potency 
compared to conventional BK, they were believed to make sense in colubrid and crotalid snake bodies 
because these BRPs resemble the plasma kinin in the kallikrein–kinin system of these predators, and the 
hypothesis needs to be tested with more target tissue preparations [30]. 
Post-translational modification of hydroxylation at position 2 or 3 occurred in some BRPs.  
The pharmacological effect of hydroxyproline modification was reported in the study of comparative 
effects of multiple BRPs on mammalian smooth muscles [31]. Four BRPs and their hydroxylated analogs 
revealed differentiated bioactive potency on different isolated smooth muscle tissues, which could be 
caused by a different metabolism pathway or even a different subtype of receptor [31]. Another special 
modification occurring in PK is the O-sulfated Tyr residue. Both modified and non-modified forms were 
reported to exhibit BK-agonist activity and the non-modified form was less potent than the O-sulfated 
form [44]. In most reported studies, both forms were isolated from the skin secretion except for a single 
study on Agalychnis callidryas, which may be due to the limited techniques for their research at that 
moment [35]. Apparently, there is a special sulfatase widely distributed in the Phyllomedusinae tree 
frogs, which contributes to the generation of PK in the skin secretion for the purpose of self-defence.  
In the process of review, there is a non-uniform nomenclature, which is causing confusion between “PK” 
and “PK sulfated” in some cases [29,30,34,42]. Considered in the first publication of PK, which is a 
sulfated form in skin secretion, it should be named the Tyr residue O-sulfated form of PK in future 
studies in order to avoid any misunderstanding. 
2.4. BRPs from Ranidae 
Family Ranidae is the most widely distributed amphibian in the world, with exceptions in Antarctica, 
southern South America and most of Australia [28]. The discovery of BRPs have been reported from the 
skin secretions of 25 species in this family, and the number of the species is approximately three times 
more than investigated species in Hylidae. They displayed the diversity of structural characteristics not 
only in their encoded kininogen precursors but also in their mature peptides. 
Similar to cDNA-encoded proprepeptides discovered from Bombinatoridae, the proprepeptides in 
Ranidae skin secretion demonstrated different forms of proprepeptides, including tandem copies 
containing proprepeptides and a single copy containing proprepeptides as well (Figure 3). However, 
their precursors demonstrated more significant and complicated patterns when compared to other 
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amphibian families. Firstly, the length of the region between the –KR– (classic prepropeptide convertase 
processing site) and the mature BRPs was longer than the precursors from the species of Hylidae. 
Secondly, more than one sequence of BRP repeatedly appeared in the proprepeptides in some cases. 
Thirdly, for BK or some BRP expressed in the same species, there were some proprepeptides containing 
a different number of copies. Due to lack of data and limited research, it was not clear why the encoded 
proprepeptides of BRPs in this family were significantly different. This phenomenon was probably due 
to the wide distribution of studied Ranidae species, their different living environments and the different 
species, which influence the expression changes of BRPs. In a sense, the variety of proprepeptides 
demonstrated the evidence of evolution among the amphibian. 
 
(a) 
(b) 
Figure 3. Cont. 
Lithobates palustris 
(A5PG36) 
MFTLKKSLLLLFFLGTISLSLC 
EQERDADEDEYAGDAKAEDV KR AGYSRVISLPAGLSPLRIAPASSRMIR RPPGFSPFRIAPASTL 
KR DADEDEYAGEAKAEDV KR AGYSRVISLPAGLSPFRIAPASTL  
KR DADEDEYAGEAKAEDV KR AGYARVISLPAGLSPLRIAPASTL  
KR DADEDEYAGEAKAEDV KR AGYARVISLPAGLSPLRIAPASTL  
KR DADEDEYAGEAKAEDV KR ARYSRENSLPAGLSPLRIAPASTL  
KR DADEDEYAGEAKAEDV KR AGIRRPPGFSPLRIAPASSRMIR RPPGFSPFRIAPAIV 
 
(A5PG37) 
MFTLKKSLLLLFFLGTISLSLC 
EQERDADEDEYAGDAKAEDV KR AGYSRVISLPAGLSPLRIAPASSRMIR RPPGFSPFRIAPASTL 
KR DADEDEYAGEAKAEDV KR AGYSRVISLPAGLSPFRIAPASTL 
KR DADEDEYAGEAKAEDV KR AGYARVISLPAGLSPLRIAPASTL 
KR DADEDEYAGEAKAEDV KR AGIRRPPGFSPLRIAPASSRMIR RPPGFSPFRIAPAIV 
 
(A5PG38) 
MFTLKKSLLLLFFLGTISLSLC 
EQERDADEDEYAGDAKAEDV KR AGYSRVISLPAGLSPLRIAPASSRMIR RPPGFSPFRIAPASTL 
KR DADEDEYAGEAKAEDV KR AGYSRVISLPAGLSPFRIAPASTL 
KR DADEDEYAGEAKAEDV KR AGIRRPPGFSPLRIAPASSRMIR RPPGFSPFRIAPAIV 
Rana guentheri  
(A0AEI1) (A0AEI2) 
MLTLKKSLLLLFFFGTISLSLC 
EQERDADEDENESRTVR VPPGFTPFRIAPASSL 
KR NADADETERRISK RPPGFSPFRIAPASSL 
KR NADADETERRISK RPPGFSPFRIAPASSL 
KR NADADETERRISK RPPGFSPFRIAPASSL 
KR NADEDENESRMVR VPPGFSPFRIAPEIV 
MLTLKKSLLLLFFFGTISLSLC 
EQERDADEDENESRTVR VPPGFTPFRIAPASSL 
KR NADADETERRISK RPPGFSPFRIAPASSL 
KR NADADETERRISK RPPGFSPFRIAPASSL 
KR NADADETERRISK RPPGFSPFRIAPASSL 
KR NADADETERRISK RPPGFSPFRIAPASSL 
KR NADEDENESRMVR VPPGFSPFRIAPEIV 
 
(A0AEI3) (A0AEI4) 
MLTLKKSLLLLFFFGTISLSLC 
EQERDADEDENESRTVR VPPGFTPFRIAPASSL 
KR NADADETERRISK RPPGFSPFRIAPASSL 
RR NADEDENESRMVR VPPGFSPFRIAPASSL 
KR NADADETERRISK RPPGFSPFRIAPASSL 
KR NADADETERRISK RPPGFSPFRIAPASSL 
KR NADEDENESRMVR VPPGFSPFRIAPEIV 
MLTLKKSLLLLFFFGTISLSLC 
EQERDADEDENEQEAKVEDV  
KR              AGYSRMI R RPPGFTPFRIAPASSV
KR NADEDENESRMI R RPPGFSPFRIAPASSV
KR NADEDENESRMI R RPPGFSPFRIAPASSV
KR NADEDENESRMI R RPPGFSPFRIAPASSV
KR NADEDENESRVAR VPPGFTPFRIAPEIV 
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(c) 
 
(d) 
Figure 3. Biosynthetic skin prepropeptides are identified from skin secretion of multiple 
species from Ranidae. (a) Three BRP precursors are identified from Lithobates palustris; 
(b) Four skin prepropeptides are identified from Rana guentheri; (c) Four prepropeptides 
were discovered from Rana chensinensis; (d) The skin prepropeptides containing single 
copies were discovered in skin secretion of multiple Ranidae species. The access numbers 
of the Uniprot database are shown at the head of each precursor. The regions shown in italic 
typeface are signal peptides. Classic prepropeptide convertase processing sites, –KR–, are 
shown in bold typeface. The regions with a single underline indicate highly conserved 
sequences as compared to conventional BK. 
The BRPs isolated from the skin secretion of Ranidae species so far are shown and aligned in Table 4. 
Compared to the BRPs identified in Hylidae, the post-translational modification occurred less frequently in 
this group. Only two studies reported modified BRP, Hyp3-BK, discovered from skin secretions of  
Hylarana guentheri and Rana temporaria [45]. However, the forms of amino acid substitutions that occurred 
in BRPs from Ranidae were more diverse than the BRPs in other amphibian families. There are some 
common substitutions including arginine replaced by valine at position 1 [46], serine replaced by threonine 
at position 6 and phenylalanine replaced by leucine at position 8, which are similar to the amino acid 
substitutions of BRPs in Hylidae and Bombinatoridae. Meanwhile, some unique BRPs such as Asp6-BK,  
Arg0, Trp4, Leu8-BK and Arg0, Leu1, Thr6, Trp8-BK were isolated in the skin secretion of Ranidae [47]. 
Rana chensinensis 
(B2FUW2)  
MFTLKKSLLLLFFLGTISLSLC  
EQERDADEDEYAGDAKAEDV KR AGYSRVISLPAGLSPLRIAPASSRMIR RPPGFSPFRIAPASTL 
KR DADEDEYAGEAKAEDV KR            AGIRRPPGFSPLRIAPASSRMIR RPPGFSPFRIAPAIV 
 
(B2FUW3)  
MFTLKKSLLLLFFLGTISLSLC  
EQERDADEDEYAGDAKAEDV KR AGYSRVISLPAGLSPLRIAPASSR MIR RPPGFSPFRIAPAIV 
 
(B2FUW4)  
MFTLKKSLLLLFFLGTISLSLC  
EQERDADEDEYAGDAKAEDV KR AGYSRVISLPAGFSPFRIAPAIV 
 
(B2FUW5)  
MFTLKKSLLLLFFLGTISLSLC  
EQERDADEDEYAGEAKAEDV KR AGYSRMIR RPPGFSPFRIAPAIV 
Amolops loloensis (A0EX85) 
MFTLKESLLLLFFLGAISLSLC  
EQERDADEEETEGGAKVETV KR APVPPGFTPFRVAPEIV 
 
Amolops wuyiensis (C4PLD1)  
MFTSKKSILLLFFLGAISLSLC  
EEERDADEDETVGEAIAENV KR AALPPGFTPFRVAPEIV 
 
Odorrana versabilis (X5JAD3) 
MFTLKKSLLLLFFLGTISLSLC  
EQERDADEDEYAGEAKAEDV KR AGYSRTISLPAGLSPLRIAPASLR MIR RPPGFTPLRIAPAIV
 
Pelophylax kl. Esculentus (E7AIL2) 
MFTMKKSLLLFFFLGIVSLSLC  
KEERDADEEENEETGGEVKVEEV KR QKTYNR RPPGWSPLRIAPTNV 
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Table 4. BRPs isolated from skin secretion of Ranidae. Peptides are aligned to compare  
with conventional BK. The proline residues with single underline represent modification  
of hydroxyproline. 
Names Peptide Sequences Species 
BK RPPGFSPFR 
Hyla arborea schelkownikowi [48]
Lithobates pipiens [49] 
Odorrana grahami [50] 
Rana chensinensis [49] 
Hylarana guentheri [46] 
Rana tagoi okiensis [51] 
Pelophylax ridibundus [47] 
Rana muscosa [52] 
Rana temporaria [45] 
desArg9-BK RPPGFSPF Rana temporaria [45,53] 
desArg1-BK PPGFSPFR Hylarana guentheri [46] 
Hyp3-BK RPPGFSPFR Hylarana guentheri [46] Rana temporaria [45] 
Thr6-BK RPPGFTPFR 
Hylarana guentheri [46] 
Rana tagoi okiensis [51] 
Pelophylax ridibundus [47] 
Thr6, Leu8-BK RPPGFTPLR Odorrana versabilis [54] 
Leu5, Thr6-BK RPPGLTPFR Odorrana grahami [50] 
Asp6-BK RPPGFDPFR Pelophylax ridibundus [47] 
Val1-BK VPPGFSPFR Hylarana guentheri [46] 
Val1, Thr6-BK VPPGFTPFR Lithobates pipiens [49] Hylarana guentheri [46] 
BK-Ile RPPGFSPFRI Pelophylax ridibundus [47] 
BK-Ile, Ala RPPGFSPFRIA Pelophylax ridibundus [47] 
BK-IAPAS RPPGFSPFRIAPAS  Pelophylax ridibundus [47] Lithobates pipiens [49] 
BK-IAPASIL RPPGFSPFRIAPASIL Rana temporaria [45,53] 
Thr6-BK-Ile, Ala RPPGFTPFRIA Pelophylax ridibundus [47] 
Thr6-BK-IAPAS RPPGFTPFRIAPAS  Lithobates pipiens [49] 
BK-VAPAS RPPGFSPFRVAPAS Odorrana schmackeri [55] 
Arg0, Trp5, Leu8-BK RRPPGWSPLR Pelophylaxkl. esculentus [56] 
IR-Leu8-BK IRRPPGFSPLR Lithobates palustris [57,58] 
IR-Leu8-BK-IA IRRPPGFSPLRIA Lithobates palustris [59,60] 
AGIR-Leu8-BK AGIRRPPGFSPLR Lithobates palustris [59,60] 
AGIR-Leu8-BK-IA AGIRRPPGFSPLRIA Rana chensinensis [49] Lithobates palustris [59,60] 
LLPIVG-BK LLPIVGRPPGFSPFR Rana temporaria [45] 
Arg0, Leu1, Thr6, Trp8-BK RLPPGFTPWR Rana sakuraii [60] 
RAA-Leu1, Thr6-BK RAALPPGFTPFR Amolops wuyiensis [61] 
RVA-Leu1, Thr6-BK RVALPPGFTPFR Amolops wuyiensis [61] 
RAEA-Val1, Thr6-BK RAEAVPPGFTPFR Hylarana nigrovittata [62] 
RAP-Val1, Thr6-BK RAPVPPGFTPFR Amolops loloensis [59] 
Thr6-kallidin KRPPGFTPFR Hylarana guentheri [46] 
RLS-Thr6-kallidin RLSKRPPGFTPFR Hylarana guentheri [46] 
The names of species Rana ridibunda, Rana palustris and Rana nigrovittata are redirected from  
Pelophylax ridibundus, Lithobates palustris and Hylarana nigrovittata respectively. 
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BPRs in this group demonstrated longer extended C-terminals and prepropeptides demonstrated two 
features from most recent reports detailed in Figure 3 [54,56]. Firstly, they are highly conserved through 
this amphibian family and they identified the regions containing an identical triple amino acids sequence, 
–IAP–, after Arg9. Secondly, the extended C-terminal regions are identical within one prepropeptide 
except the one following the last copy of the putative mature peptide. These extensions are not only 
displayed in their encoded proprepeptides but also identified from their skin secretion such as  
BK-IAPASIL, a heptapeptide extension [45]. It was also reported that the C-terminal extended BRPs 
were identified using high resolution mass spectra analysis, along with sequences, which the amino acid 
residue at C-terminals removed subsequently such as RL-16, RS-15, RS-14, RA-13, RP-12, RA-11,  
RV-10 and BK from the skin secretion of five Rana species [53,63]. Apparently, this indicates a 
complicated pathway for mature peptide release or metabolization. Accordingly, it has raised a question 
as to what is the right sequence of mature BRPs in the amphibian skin defence strategy. 
The structural characteristic of N-terminal extended BRPs is much similar to the situation of  
C-terminal extension. There is a highly conserved region in the front of putative mature BRPs in their 
prepropeptides precursors. In the report of the BRPs isolated from Rana palustris (name redirected from 
Lithobates palustris) [57], the N-terminal extended sequence, –AGIR– was located between –KR– and 
the mature peptide sequence. It probably indicates these BRPs were liberated from smaller kininogenin 
amphibian skin so that both extensions of C- and N-terminals consist of their kininogen precursor. 
Meanwhile, a special N-terminal extension occurred in this family, by which the putative mature BRPs 
contain an inserted fragment regionlike sequence, –APV–, first reported in isolated BRPs from  
Amolops loloensis [59], known as amolopkinin, following a report of an insertion of –AEAV– in the 
BRPs from Hylarana nigrovittata [62]. However, the report of insertions inamolopkinin-W1 and W2 
from Amolops wuyiensis were not mentioned though these two BRPs showed inserted sequence  
V/A-AL in their sequences [61]. In another respect, the BRPs containing the inserted region could also 
be regarded as a form of N-terminal extension occurring in the BRPs with Val1 or Leu1 substitution. 
3. Pharmacological Activities of Isolated BRPs 
In 1909, the kallikrein–kinin system (KKS) was discovered by Abelous and Bradier by observing a 
decrease of blood pressure in humans after the intravenous injection of components extracted from 
human urine [64]. Since then, this system has been intensively investigated and proven to be an important 
endogenous and spontaneous metabolic cascade found in many species. The activities of the KKS 
gravitate around the release of a series of vasoactive kinins, such as BK, that participate in control of 
blood pressure, inflammatory and cardioprotective processes [65]. Further clinical applications have 
arisen from recent studies on signalling pathways for their receptors, B1 and B2, such as a promising 
tumour and inflammatory treatment through the Ras/Raf/MEK/MAPK pathway [66–68]. 
BRPs have a wide distribution among amphibian species and are a component of their innate defence 
system. They demonstrate a highly conserved sequence as compared to mammalian BK with multiple 
structural modifications, which indicates unique characteristics for targeting the plasma system or 
smooth muscle receptors of their predators, such as birds and snakes. Although more than 50 different 
BRPs have been isolated from amphibian skin secretion, nearly half of them report pharmacological 
activity on isolated mammalian smooth muscle preparations (Table 5). Most of these illustrated agonized 
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activity on BK receptors with a variety of potency but some appeared to be antagonists. In relation to 
the conventional BK sequence, Arg1, Pro2, Gly4, Phe5, Pro7, Phe8 and Arg9 are necessary components 
for its biological activity; thus, amino acid substitution and modification could enhance or reduce the 
potency and even change an agonist into antagonist [69]. 
Val1 and Thr6 were the most common amino acid substitution of BRPs from amphibian skin secretion. 
In comparison to BK, Val1-BK had a less potent effect on the rat ileum and demonstrated barely any 
activity on arteries [46]. The Thr6-BK was reported to demonstrate an equivalent effect to BK on the 
isolated rat artery but having two-fold maximum contraction with higher EC50 on rat ileum [23].  
As expected, their analogues which contain post-translational modifications including C-terminal 
extension and hydroxylation at position 2 or 3 demonstrated less potent pharmacological effects although 
their structure–activity relationship has not been explained clearly [25,31]. 
There were some BRPs from amphibian skin secretion which exhibited potent antagonist activity. 
DesArg9, Leu8-BK was reported as a B1 receptor antagonist on the rabbit aorta and artery [70].  
In reviewed peptides, two BRPs, Arg0, Trp5, Leu8-BK and pGlu1, Ile2, Leu5, Gly6, Leu8-BK, induced 
inhibitory activity against BK induced vascular relaxation. The former induced a 70% reduction of 
relaxation, and the latter inhibited the response of BK almost completely and it has been confirmed that 
its antagonist activity was mediated through the B2 receptor [26,56]. It was reported that Phe at position 
8 of BK is one of the important sites for activating BK receptors, and the substitution of Leu could induce 
an antagonist activity [71]. However, a report of Thr6, Leu8-BK displayed an agonist activity, which 
produced a 336-fold decrease of EC50 on rat ileum and a 10-fold decrease of EC50 but increased 
contractions of the uterus as compared with BK [54]. Compared to the antagonists discussed above, 
Thr6, Leu8-BK demonstrated a higher similarity to the amino acid sequence of conventional BK, which 
may remain potent on activating isolated tissues and it also could be explained that rat ileum and uterus 
have different types and distributions of receptors as compared with smooth artery muscles. 
BRPs containing different terminal extensions exhibited different patterns of bioactive activity.  
RAA-Leu1, Thr6-BK and RVA-Leu1, Thr6-BK isolated from Amolops wuyiensis were reported as BK 
antagonists [61]. However, the two highly similar analogues of RAP-Val1, Thr6-BK from the same 
genus, Amolops loloensis and RAEA-Val1, Thr6-BK from Hylarana nigrovittata exhibited activities of 
BK agonists on guinea pig ileum [62]. Thereby, this indicates that BRP receptors may have different 
subtypes in mammalian species, which contribute to remarkable pharmacological effects. Another 
probable explanation for their structure indicates that the Val1 substituted BRP demonstrates a more 
potent agonistic behaviour than Leu1 substitution. In addition, the BPR containing the longest N-terminal 
extension, Bombinakinin M, is a B2 receptor selective agonist and it was proven that it caused prolonged  
signalling [72]. The longer extended region possibly decreased affinity of aminopeptidase binding, 
which might prolong the interaction time between BRPs and receptors. The C-terminal extensions 
influenced the potency of BRPs as well. When comparing AV-12 with AR-10, C-terminals extended 
region encoded within a –VV dipeptide, resulted in a nearly 30% reduction of BK induced maximal 
vascular relaxation [17]. However, PK demonstrated that a dipeptide extension as –IY was more potent 
than BK on the blood pressure of a dog [44]. 
It is currently not possible to explain the diversity of pharmacological effects of BRPs which have 
been isolated from amphibian skin secretion. The hypotheses are usually raised through differential 
ligand-receptor binding pathways caused by changes of BRPs structural conformations including the 
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extensions and amino acid substitutions. One probable reason could be that these changes prevent the 
peptide degradation by endogenous enzymes, which induce a decrease of metabolic effects [65,73]. 
Considering that the function of venomous skin secretion is protection and defence, different BRPs may 
have specific targets on either the plasma systems or intestinal smooth muscle of various animals that 
are preying on amphibians. This may be true because related BRP analogs have been isolated and 
identified from mammals, birds, reptiles and fish [15,37,54,56]. 
Table 5. Pharmacological effects of selected BRPs grouped as BK agonist and antagonist. 
BRPs Pharmacological Effect 
Agonist 
RPPGFTPLR Contract the rat ileum; increase contraction frequency in the rat uterus [54].
RPPGFTPFR 
RPPGFTPFR 
RPPGFTPFRVD 
RPPGFTPFRVD 
Activating mammalian arterial smooth muscle bradykinin receptors;  
contract rat ileum, bladder and uterine [31,34]. 
VPPGFTPFR 
VPPGFTPFR 
VPPGFTPFRQS 
VPPGFTPFRQS 
Contract the rat ileum and guinea pig ileum preparations [31,34]. 
RPAGFTPFR 
VPTGFTPFR Relax pre-contracted rat arterial, contract rat ileum [25]. 
RPPGFSPFRIY Decrease dog blood pressure [44]. 
RAPVPPGFTPFR 
RAEAVPPGFTPFR Contractile effects on isolated guinea pig ileum [59]. 
DLPKINRKGPRPPGFSPFR Contract guniea pig ileum; B2 receptor selective agonist [72]. 
Antagonist 
RPPGFSPL B1 receptor antagonist on the rabbit aorta and artery [70]. 
RRPPGWSPLR Antagonize the relaxation in rat arterial smooth muscle  induced by bradykinin [26,56]. 
RVALPPGFTPFR 
RAALPPGFTPFR 
Antagonize the contractile effects of bradykinin on isolated  
rat ileum smooth muscle preparations [61]. 
RVALPPGFTPLR B2 receptor antagonist on rat tail artery [74]. 
QIPGLGPLR B2 receptor antagonist on the rat artery [26,56]. 
4. Conclusions 
Many studies around the world have indicated that amphibians are a virtual goldmine for further 
discovery of new drugs in relation to new therapeutic applications. Amphibians generate BK or BRPs 
in their skin secretion instead of releasing them into plasma. Regarding the natural roles of these BRPs, 
the hypothesis is that they act as skin defence compounds mediated on the BK receptor of their predators. 
Firstly, the BK or BRPs are abundant in the skin secretions, which were analysed using liquid 
chromatography systems in the reviewed papers. From the perspective of evolution, it makes sense that 
the amount of BK or BRPs should contribute to the skin defence strategy. Secondly, some BRPs have 
been identified in the plasma of the species which prey on amphibians, such as Val1, Thr6-BK in snakes, 
Leu2, Thr6-BK in lizards and Thr6, Leu8-BK in birds [15]. Meanwhile, homologues were also detected 
in the skin secretion of amphibians, which could target the specific BK receptor of their predators. It is 
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speculated that sufficient amounts of BRPs could stimulate the gastrointestinal system resulting in 
vomiting reflex and ejection. Differences in the primary structure of BPRs in the amphibian skin 
secretion varies along with the plasma kinins in the predator species and differences in the primary 
structure of the receptors do exist, specifically between phylogenetically distant animals. However,  
some uncertainties remain. It is not clear how the BRPs affect the predator. Furthermore, considering 
that a variety of predator species still prey on amphibians, how are these able to overcome the effect of 
the BRPs secreted by their prey? Zhou et al. proposed that these BRPs genes became pseudogenes in 
amphibians [75]. In this regard, further studies are necessary to investigate the specificity of the 
interaction mechanism between BRPs and BK receptors in predators, as well as phylogenetic research 
on the BRPs and related receptors of both predators and the amphibians themselves. 
BRPs from amphibian skin secretion are diverse and they provide a natural-selected sequence 
storehouse for physiological and pharmacological screening. In the reviewed paper, the activity of the 
studied BRPs was highly variable. Considering they were subjected to smooth muscle assays for 
biological screening, there was only limited data obtained by the authors by which to deduce the 
relationship between function and structure. In order to explain the manner through which BRPs interact 
with BK receptors to induce agonist and antagonist activity, it is essential to perform a more accurate 
research approach to evaluate the affinity of the ligand–receptor interaction, as well as their specificity, 
which is dependent on their spatial structural characteristics. 
It is not possible to identify significant candidates for clinical use through BRPs from amphibian skin 
secretion due to the limited amount of high quality data currently available. However, it brings new 
insights for biotechnological application. Charest-Morin et al. fused bombinakinin M to the enhanced 
green fluorescent protein (EGFP) with a slight change of affinity of bombinakinin M binding to B2 
receptor [76]. Due to resistance to peptideases, the N-terminal extension between receptor binding region 
and EGFP becomes a suitable spacer, which is not able to interfere with the conformation for activating 
B2 receptor. As a potential source, BRPs constitute the innate defence system of amphibians, while 
providing a diversity of structural characteristics. Comprehensive and systematic studies of the physiological 
and pharmacological activities of BRPs from amphibian skin secretions are needed in the future. 
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